, Tracking Stock Market Picks
Enter Symbol:
Novo Nordisk A/s (NVO) [hlAlert]

up 16.44 %

Novo Nordisk A/s (NVO) upgraded to Buy by BofA/Merrill

Posted on: Tuesday,  Feb 25, 2014  9:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Novo Nordisk A/s (NYSE: NVO) on 02/25/2014, when the stock price was $48.23. Since
then, Novo Nordisk A/s has gained 16.44% as of 01/08/2016's recent price of $56.16.
If you would have followed this BofA/Merrill's recommendation on NVO, you would have gained 16.44% of your investment in 682 days.

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/25/2014 9:25 AM Buy
as of 10/17/2014
1 Week up  1.60 %
1 Month down  -8.56 %
3 Months down  -2.95 %
1 YTD down  -8.10 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/17/2013 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy